Results of a Phase 2 Clinical Trial at 48 Weeks (AI424-007): A Dose-Ranging, Safety, and Efficacy Comparative Trial of Atazanavir at Three Doses in Combination with Didanosine and Stavudine in Antiretroviral-Naive Subjects-Reference-Cited by-同舟云学术

Results of a Phase 2 Clinical Trial at 48 Weeks (AI424-007): A Dose-Ranging, Safety, and Efficacy Comparative Trial of Atazanavir at Three Doses in Combination with Didanosine and Stavudine in Antiretroviral-Naive Subjects

Published:2003-01 Issue:1 Volume:32 Page:18-29
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes

Author:

Sanne Ian,Piliero Peter,Squires Kathleen,Thiry Alexandra,Schnittman Steven

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference36 articles.

1. Decline in deaths from AIDS due to new antiretrovirals

2. Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection

3. A phase II safety and efficacy study of amprenavir in combination with zidovudine and lamivudine in HIV-infected patients with limited antiretroviral experience

4. A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less

5. A Randomized, Double-blind Trial Comparing Combinations of Nevirapine, Didanosine, and Zidovudine for HIV-Infected Patients

Cited by 194 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Applications of the hollow-fibre infection model (HFIM) in viral infection studies;Journal of Antimicrobial Chemotherapy;2022-11-22

2. Natural products and synthetic analogues against HIV: A perspective to develop new potential anti-HIV drugs;European Journal of Medicinal Chemistry;2022-04

3. Comparison of the Efficacy and Safety of Atazanavir/Ritonavir Plus Hydroxychloroquine with Lopinavir/Ritonavir Plus Hydroxychloroquine in Patients with Moderate COVID-19, A Randomized, Double-blind Clinical Trial;IRAN J PHARM RES;2021

4. A Scalable Synthesis of Biaryl Unit of the HIV Protease Inhibitor Atazanavir;Letters in Organic Chemistry;2019-12-12

5. GII.4 Norovirus Protease Shows pH-Sensitive Proteolysis with a Unique Arg-His Pairing in the Catalytic Site;Journal of Virology;2019-03-15